InsiderClue
Insiders · Profile

RIEDEL NORBERT G

Director at Jazz Pharmaceuticals · Director at Eton Pharmaceuticals · Corporate Vice President at Baxter International. Filing since 5 Jun 2007. CIK 0001161662

JAZZ Jazz Pharmaceuticals plc Director · 14 trades ETON Eton Pharmaceuticals, Inc. Director · 1 trade BAX Baxter International Corporate Vice President · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
JAZZ Jazz Pharmaceuticals plc
27 Feb 2026
Director
Sold at will
3,415
$655.68K
32.7%
JAZZ Jazz Pharmaceuticals plc
14 Aug 2023
Director
Sold at will
1,241
$171.45K
8.3%
JAZZ Jazz Pharmaceuticals plc
8 Aug 2022
Director
Sold, plan not stated
1,089
$165.88K
8.4%
JAZZ Jazz Pharmaceuticals plc
5 Aug 2022
Director
Sold, plan not stated
8,000
$1.25M
43.5%
JAZZ Jazz Pharmaceuticals plc
6 Aug 2021
Director
Sold, plan not stated
1,306
$193.24K
11.2%
JAZZ Jazz Pharmaceuticals plc
7 Aug 2020
Director
Sold, plan not stated
931
$117.19K
9.0%
JAZZ Jazz Pharmaceuticals plc
9 Aug 2019
Director
Sold, plan not stated
726
$98.48K
8.6%
ETON Eton Pharmaceuticals, Inc.
15 Nov 2018
Director
Bought
5,000
$30.00K
9.1%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2018
Director
Sold, plan not stated
660
$116.56K
9.2%
JAZZ Jazz Pharmaceuticals plc
11 Aug 2017
Director
Sold, plan not stated
662
$94.25K
10.5%
JAZZ Jazz Pharmaceuticals plc
15 Aug 2016
Director
Sold, plan not stated
633
$86.37K
11.3%
JAZZ Jazz Pharmaceuticals plc
16 May 2016
Director
Sold, plan not stated
644
$93.51K
13.2%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2015
Director
Sold, plan not stated
801
$144.18K
14.1%
JAZZ Jazz Pharmaceuticals plc
12 May 2015
Director
Sold, plan not stated
650
$113.01K
13.0%
JAZZ Jazz Pharmaceuticals plc
28 May 2014
Director
Sold, plan not stated
644
$91.76K
16.1%
BAX Baxter International
3 Aug 2012
Corporate Vice President
Sold, plan not stated
70,125
$4.14M
57.0%
BAX Baxter International
5 Mar 2010
Corporate Vice President
Sold, plan not stated
75,600
$4.48M
60.1%
BAX Baxter International
2 Dec 2009
Corporate Vice President
Sold, plan not stated
92,500
$5.17M
71.7%
BAX Baxter International
27 Jan 2009
Corporate Vice President
Sold, plan not stated
80,000
$4.65M
67.7%
BAX Baxter International
26 Jan 2009
Corporate Vice President
Sold, plan not stated
22,300
$1.29M
36.9%
BAX Baxter International
6 Jun 2007
Corporate Vice President
Sold, plan not stated
39,700
$2.28M
49.6%
BAX Baxter International
5 Jun 2007
Corporate Vice President
Sold, plan not stated
54,584
$3.14M
57.5%
22 decisions on file.